Can you take Iron bisglycinate with Panase?
1 drug interaction and 4 additional warnings found for the following 2 drugs:
- iron bisglycinate
- Panase (pancrelipase)
Drug interactions
Moderate drug interactions
Moderate:
pancrelipase iron bisglycinate
Applies to: Panase (pancrelipase) and iron bisglycinate
Pancrelipase may reduce the effectiveness of folic acid and iron by interfering with their absorption. To prevent or minimize the interaction, you should separate the dosing times of pancrelipase and any product containing folic acid or iron by as much as possible. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Food/lifestyle interactions
Moderate food/lifestyle interactions
Moderate:
iron bisglycinate Food/Lifestyle
Applies to: iron bisglycinate
Food may reduce the absorption and blood levels of iron bisglycinate. In addition, some oral medications can also interfere with iron bisglycinate absorption into the bloodstream, which may make the medication less effective in treating your condition. Likewise, iron bisglycinate may interfere with the absorption of other orally administered medications. You should take iron bisglycinate on an empty stomach at least one hour before or two hours after a meal. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. Talk to your doctor or pharmacist if you have questions about how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Moderate:
pancrelipase multivitamins with minerals
Applies to: Panase (pancrelipase)
Pancrelipase may reduce the effectiveness of folic acid and iron by interfering with their absorption. To prevent or minimize the interaction, you should separate the dosing times of pancrelipase and any product containing folic acid or iron by as much as possible. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Disease interactions
2 potential interactions Applies to: 2 conditions, including Gout and Renal Dysfunction.
Gout
Moderate:
Panase
The pancrelipase in Panase has a moderate potential interaction with Gout.
Porcine-derived pancreatic enzyme products contain purines that may increase blood uric acid levels. Extremely high dosages of exogenous pancreatic enzymes have also been associated with hyperuricosuria and hyperuricemia. Therapy with pancrelipase should be administered cautiously in patients with preexisting hyperuricemia, gout, or renal impairment. Monitoring of serum uric acid levels is recommended.
Renal Dysfunction
Moderate:
Panase
The pancrelipase in Panase has a moderate potential interaction with Renal Dysfunction.
Porcine-derived pancreatic enzyme products contain purines that may increase blood uric acid levels. Extremely high dosages of exogenous pancreatic enzymes have also been associated with hyperuricosuria and hyperuricemia. Therapy with pancrelipase should be administered cautiously in patients with preexisting hyperuricemia, gout, or renal impairment. Monitoring of serum uric acid levels is recommended.
More resources
iron bisglycinate
A total of 89 drugs are known to interact with iron bisglycinate.
- Iron bisglycinate is in the drug class iron products.
- Iron bisglycinate is used to treat the following conditions:
Panase
A total of 26 drugs are known to interact with Panase.
- Panase is in the drug class digestive enzymes.
- Panase is used to treat the following conditions:
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.